Business TechU.S. Senate probes pricing of Hepatitis C drug Sovaldi There’s no question to Sovaldi’s efficiency as a Hepatitis C treatment, but can patients afford a $1000 pill? Policymakers questioned the cost of the drug and launched an investigation into the matter.by Lori Sandoval
